牙种植治疗中软组织增量干预的结局指标与评估方法:近10年临床研究的系统综述
本系统综述遵循PRISMA 2020并注册于PROSPERO,检索近10年临床研究,纳入92篇文章(39项RCT、20项非RCT、33项病例系列),旨在识别和报告牙种植治疗中软组织增量干预的结局指标与评估方法。结局分为研究者评估指标与患者报告结局指标(PROMs),临床结局报告最频繁,PROMs报告不足但作者认为应视为未来临床研究的方法学组成部分。
要点
- 共纳入92篇文章,其中39项RCT、20项非RCT、33项病例系列研究。
- 临床结局是报告最频繁的结局类型,PROMs一般报告不足。
- PROMs应被视为未来临床研究的方法学组成部分。
核心结论
- 近10年种植体周围软组织增量临床研究逐渐增多,临床结局指标报告最频繁,但领域趋势显示从传统临床评估方法向数字技术使用转变,PROMs一般报告不足但应被视为未来临床研究的方法学组成部分。
研究设计与样本
- 遵循PRISMA 2020的系统综述,方案注册于PROSPERO(CRD42021252214),检索符合预设纳入标准的文章并提取结局指标数据。
- 共纳入92篇文章,其中39篇报告随机对照试验(RCT)、20篇非RCT、33篇病例系列研究。
主要发现
- 结局指标分为研究者评估结局指标(临床、数字影像、美学、组织学、生物标志物和安全性)与患者报告结局指标(PROMs)。
- 临床结局是报告最频繁的结局类型。
- 在所有类别中,报告最频繁的主要结局为临床方法评估的面部黏膜厚度(22.83%)、临床方法评估的面部角化黏膜宽度(19.57%)、临床方法评估的面部黏膜边缘位置/退缩(18.48%)、数字影像方法评估的面部黏膜厚度(11.96%)、数字影像方法评估的面部软组织体积(9.78%)和临床方法评估的嵴上组织高度(9.78%)。
- 未观察到特定类型或质量(偏倚水平)的临床研究与主要结局选择之间存在可辨别的关联模式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To identify and report outcome measures and methods of assessment on soft tissue augmentation interventions in the context of dental implant therapy reported in clinical studies published in the last 10 years. MATERIALS AND METHODS: The protocol of this Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) 2020-compliant systematic review was registered in PROSPERO (CRD42021252214). A literature search was conducted to identify articles that met the pre-established eligibility criteria. Data of interest, with an emphasis on outcome measures, were extracted. For each outcome, specific methods and timing of assessment were described in detail. Following a critical qualitative analysis of the data, outcome measures were categorized. Primary outcomes were identified, and the frequency of reporting in the selected articles was calculated. Additionally, risk-of-bias assessments were performed for individual articles and primary outcomes. RESULTS: Ninety-two articles, of which 39 reported randomized controlled trials (RCTs), 20 non-RCTs, and 33 case series studies, were selected. Outcome measures were categorized into either investigator-evaluated outcome measures (i.e., clinical, digital imaging, aesthetic, histological, biomarker, and safety) or patient-reported outcome measures (PROMs). Clinical outcomes were the most frequently reported type of outcome. Considering all categories, the most frequently reported primary outcomes were facial mucosa thickness assessed with clinical methods (22.83%), facial keratinized mucosa width assessed with clinical methods (19.57%), facial mucosal margin position/recession assessed with clinical methods (18.48%), facial mucosa thickness assessed with digital imaging methods (11.96%), facial soft tissue volume assessed with digital imaging methods (9.78%), and supracrestal tissue height assessed with clinical methods (9.78%). No distinguishable patterns of association between specific types or quality (level of bias) of clinical studies and the choice of primary outcomes were observed. CONCLUSIONS: Clinical research on peri-implant soft tissue augmentation has progressively increased in the last 10 years. Although clinical outcome measures were the most frequently reported outcomes in the selected literature, trends in the field are indicative of a shift from traditional clinical assessment methods to the use of digital technologies. PROMs were generally under-reported but should be considered an integral methodological component in future clinical studies.
引用
- Avila-Ortiz G, Couso-Queiruga E, Pirc M, et al. Outcome measures and methods of assessment of soft tissue augmentation interventions in the context of dental implant therapy: A systematic review of clinical studies published in the last 10 years. J Clin Periodontol. 2022. PMID: 35088421. doi:10.1111/jcpe.13597
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。